| 000 | 01747 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514024123.0 | ||
| 264 | 0 | _c20020306 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0163-2116 | ||
| 024 | 7 |
_a10.1023/a:1013742727165 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAkuta, Norio | |
| 245 | 0 | 0 |
_aLong-term clinical remission induced by corticosteroid withdrawal therapy (CSWT) in patients with chronic hepatitis B infection: a prospective randomized controlled trial--CSWT with and without follow-up interferon-alpha therapy. _h[electronic resource] |
| 260 |
_bDigestive diseases and sciences _cFeb 2002 |
||
| 300 |
_a405-14 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xanalysis |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aSuzuki, Fumitaka | |
| 700 | 1 | _aTsubota, Akihito | |
| 700 | 1 | _aArase, Yasuji | |
| 700 | 1 | _aSuzuki, Yoshiyuki | |
| 700 | 1 | _aSomeya, Takashi | |
| 700 | 1 | _aKobayashi, Masahiro | |
| 700 | 1 | _aSaitoh, Satoshi | |
| 700 | 1 | _aIkeda, Kenji | |
| 700 | 1 | _aKumada, Hiromitsu | |
| 773 | 0 |
_tDigestive diseases and sciences _gvol. 47 _gno. 2 _gp. 405-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1013742727165 _zAvailable from publisher's website |
| 999 |
_c11763804 _d11763804 |
||